Germany prazosin market is estimated to decline at a CAGR of around -2.6% during the forecast period. However, the presence of a quality healthcare system and favorable government policies in the country is somehow driving the market in the region. As per the Institute for Health Metrics and Evaluation, around 192,000 cases of strokes were registered in the country in 2017 with a slight increment from 2014. Ischemic stroke is the leading stroke among all others in the country. The use of prazosin in PTSD cure is also considerable in Germany. In 2019, a study was conducted to determine PTSD and depression rates among paramedics. The PTSD rate among emergency medical service staff is considered to be higher than those in the general population. Around 2,731 paramedics and emergency physicians participated in the survey. The survey concluded that 5.4% of respondents had a positive PTSD screening result. In particular, older employees were significantly more likely to test positive for PTSD, the rate is 12.2% of those over 50 years, compared to 2.8% of those under 30 years.

Request a Free Sample of our Germany Prazosin Market: https://www.omrglobal.com/request-sample/germany-prazosin-market

Germany prazosin market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for a significant share in the Germany prazosin market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, Prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarctions.

A full Report of Germany Prazosin Market is Available at: https://www.omrglobal.com/industry-reports/germany-prazosin-market

Germany Prazosin Market Segmentation

By Application

• Cardiovascular Disease(CVD)
• Neurological Syndromes
• Prostate Disorders
• Kidney Disorders

Company Profiles

• Apotex Inc.
• Axon Medchem LLC
• Cayman Chemical Co.
• Merck KGaA
• Pfizer Inc.
• R&D Systems Inc.
• Renata Ltd.
• Mylan N.V.
• Sun Pharmaceuticals Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-prazosin-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404